Heart rate monitoring to predict biologic therapy response in IBD
Part of Brain & nervous system, Digestive system, Mental health clinical trials.
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis or Crohn's disease for at least 3 months.
- You are starting infliximab or vedolizumab (biologics) for the first time.
- You can wear a small heart rate monitor device and agree to the study.
- You are not taking more than one biologic at the same time.
- You have not had IBD-related surgery in the last 4 weeks or plan any during the study.
- You do not have severe anxiety or depression that is not controlled, or take certain heart medications that cannot stay at a stable dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your blood tests (inflammation levels) change after you start or adjust your treatment for ulcerative colitis or Crohn's disease. It also checks how your gut heals by looking at tissue samples from a follow-up colonoscopy.
This study is testing a new way to check inflammation in people with active IBD using non-invasive devices (like a smartwatch or sensor). It aims to find a simpler method than blood tests or stool samples, which could help manage your condition more easily.
This study tests whether digital tools, like a smartphone app and a wearable activity tracker, can help monitor your inflammatory bowel disease (IBD). You would use these tools and answer questionnaires to help doctors better understand your condition.
This trial tests whether remote monitoring, using an app and home stool tests, can be a safe alternative to frequent clinic visits for people with stable IBD. If you qualify, you'll have fewer in-person appointments and more flexibility.
This study tests whether data from your own smartwatch or smartphone can help detect when your Crohn's disease or ulcerative colitis flares up. If you join, you'll use your own device, and no extra equipment will be provided.
This study compares different blood tests that measure the amount of biologic medication in your body. The goal is to see if simpler tests give the same results as standard ones, which could make monitoring easier for patients with inflammatory bowel disease.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.